MyFinsight
Home
About
Contact
vtgn: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, VTGN has $80,929K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
80,929
68,924
Total stockholders equity
66,339
56,765
Total liabilities and stockholders equity
80,929
68,924
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$1,759K
Marketable securities
$14,389K
Cash and cash
equivalents
$62,786K
Other assets
$405K
Right-of-use asset -
operating lease
$1,074K
Property and equipment,
net
$516K
Total current assets
$78,934K
Total assets
$80,929K
Total liabilities and
stockholders equity
$80,929K
Total stockholders
equity
$66,339K
Total liabilities
$14,590K
Accumulated deficit
-$442,144K
Treasury stock, at cost,
4,522 shares of common...
$3,968K
Accumulated other
comprehensive income
$14K
Additional paid-in capital
$512,398K
Operating lease
obligation - non-current...
$610K
Deferred revenue -
non-current portion
$336K
Total current
liabilities
$13,644K
Common stock, 0.001 par
value 325,000,000...
$39K
Operating lease
obligation - current...
$597K
Deferred revenue -
current portion
$2,141K
Note payable
$658K
Accrued expenses
$8,417K
Accounts payable
$1,831K
Buy me a coffee
Vistagen Therapeutics, Inc. (VTGN)
Vistagen Therapeutics, Inc. (VTGN)